04/28/2022
The Drug and Alcohol Testing Institute is honored to announce the speaking engagement of David K***z, PhD, F-ABFT at our 2022 Annual Summit in Colorado Springs, Colorado on June 13th and 14th.
David K***z, PhD, is the Executive Director for Analytical Toxicology at Clinical Reference Laboratory in Lenexa, Kansas. Dr. K***z is Co-Responsible Person for the SAMHSA laboratory and the College of American Pathologists (CAP) forensic drug testing Scientific Director. He holds a laboratory director license in a number of states and is an inspector for SAMHSA and CAP forensic programs.
Dr. K***z is a Board Certified Toxicologist and is a national expert in urine adulteration and drug detection. Dr. K***z has worked in workplace drug testing for the past 31 years and has testified extensively regarding drug use, interpretation, and adulteration of urine, hair, oral fluid and sweat samples using GC/MS and LC/MS/MS. The primary research focus the last five years has been in the development of testing panels for synthetic cannabinoids and bath salts in urine and oral fluids and development of LC/MS/MS methods for workplace drug testing.
Dr. K***z is an inspector for the SAMHSA and CAP forensic drug testing programs and a past member of the national Drug Testing Advisory Board, NLCP MSMS Standards Working Group, SAMHSA MRO Manual for Urine/Oral Fluid Working Group, and editorial board for Clinical & Forensic Toxicology News. Dr. K***z is currently serving as a consultant to the MRO Examination Development Committee for the Medical Review Officer Certification Council (MROCC), lecturer for AAMRO training courses, and member of CAP Toxicology Resource Committee.
Dr. K***z will be providing updates from the lab prospective, answering in-person questions, and discussing HHS Oral Fluids developemnts and their likely potential significance on DOT testing in the near future.
Register now at www.datinstitute.com
